Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Halozyme Therapeutics Wins Big on Roche License Agreement

Halozyme Therapeutics Inc. (NASDAQ: HALO) saw its shares make a handy gain early on Thursday after the firm announced that it licensed its Enhanze drug-delivery technology to Roche for exclusive ...
Read Full Story »
biotech word cloud

Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday

As the markets are continuing to heat up a few biotech and pharma companies made massive gains on Thursday. There is a very positive sentiment in the health care sector ...
Read Full Story »
graph

3 Top Biopharma Movers of the Past Week

Over the past week, a few biotech companies made impressive runs. These moves were the result of positive trial results and a U.S. Food and Drug Administration (FDA) meeting. The ...
Read Full Story »
biotech word cloud

4 Top BioPharma Movers of the Past Week

Over the past week, a few biotech companies made absolutely massive runs, either up and down. In the past year, the health care sector was on fire from positive trials, ...
Read Full Story »
Female patient on gurney

Halozyme Therapeutics Sinks on Business Update

Halozyme Therapeutics Inc. (NASDAQ: HALO) hit a new 52-week low in Monday’s session following the release of a business update at JPMorgan’s 34th Annual Healthcare Conference. Needless to say, this ...
Read Full Story »
health care

How Halozyme Will Continue to Grow With Its New Deal

The roar from the health care sector has been loud and long. It was built on the innovations of many firms releasing positive results from their clinical trials, as well ...
Read Full Story »
ten bucks

13 Analyst Stocks at $10 and Under With Huge Implied Upside

Many investors are looking for where to put their money now that the Dow Jones Industrial Average has hit 18,000. What has been proven time and again in 2014 is ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Monsanto, Virgin America and More

With stocks indicated slightly higher after the Dow Jones Industrial Average closed above the vaunted 18,000 level, investors will look to extend gains and perhaps see yet another day of ...
Read Full Story »
biotech

4 Key Positive Biotech Stock Catalysts Coming Very Soon

Investors and speculators often flock to the world biotech for emerging drugs of the future. It is no secret at all that the biotech sector is full of all sorts ...
Read Full Story »
95992888

12 Analyst Stocks to Buy Under $10 With Massive Upside Potential

Stocks are looking for their footing after having hit new all-time highs in the prior week. Volatility has returned, but investors are looking at individual stock picks rather than just ...
Read Full Story »
buy sell

Twelve Analyst Stocks Trading Under $10 With Huge Implied Upside

Stocks have pulled back from their all-time highs after escalation of civil war in Iraq, but Friday managed to close higher. Investors remain bullish, and they keep hearing that the ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More

Stocks have marginally pulled back from their all-time highs early this week. Investors are being told over and over the raging bull market has changed into a stock picker's market ...
Read Full Story »
DNA

Halozyme Gets New Hope for Shareholders, and for Pancreatic Cancer Patients

Halozyme Therapeutics Inc. (NASDAQ: HALO) saw its stock surge on Thursday on news reports that the U.S. Food and Drug Administration (FDA) has removed its clinical hold on patient enrollment ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Citigroup, Equinix, IBM, Visa, Yahoo, Walmart and More

Stocks have been trying to recover from their sell-off, but investors remain wary. Equity investors want upside from stocks, but they also want to avoid a market correction or a ...
Read Full Story »
DNA

Pancreatic Cancer Trial Enrollment Halt Damages Halozyme

Halozyme Therapeutics Inc. (NASDAQ: HALO) will need some therapeutics of its own, as are its shareholders. Its shares got pounded Friday morning on news of a temporary halt of its ...
Read Full Story »